Consultant plastic, reconstructive and aesthetic surgeon Mr Dalvi Humzah outlines the development of new and existing toxins
Following our most successful conference and exhibition to date, Aesthetics reflects on the biggest weekend of 2019.
Dr Lee Walker outlines the possible strategies for managing patient pain for aesthetic procedures
Ms Natasha Berridge and Mr Mahesh Kumar discuss the recognition, diagnosis and management of facial hyperhidrosis
Dr Souphiyeh Samizadeh explores the science and pharmacological differences of botulinum neurotoxin formulations
US-based medical aesthetic company Evolus Inc has begun a consumer campaign in the US called ‘#NEWTOX NOW’ in the hope to encourage patients to use its botulinum toxin.
The results of two studies conducted by pharmaceutical company Galderma (UK) Limited have demonstrated high patient satisfaction for the use of Azzalure (AbobotulinumtoxinA), its botulinum toxin type A product, in the glabellar complex.